JAMES WILLIAM JOHNSON - 28 Nov 2022 Form 4 Insider Report for CHEVRON CORP (CVX)

Role
Executive Vice President
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for James William Johnson
Issuer symbol
CVX
Transactions as of
28 Nov 2022
Net transactions value
-$9,556,072
Form type
4
Filing time
30 Nov 2022, 16:47:30 UTC
Previous filing
03 Nov 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $5,955,792 +50,800 $117.24 50,800 28 Nov 2022 Direct F1
transaction CVX Common Stock Options Exercise $6,328,560 +56,000 +110% $113.01 106,800 28 Nov 2022 Direct F1
transaction CVX Common Stock Options Exercise $4,046,826 +36,666 +34% $110.37 143,466 28 Nov 2022 Direct F1
transaction CVX Common Stock Sale $9,587,605 -53,671 -37% $178.64 89,795 28 Nov 2022 Direct F1, F2
transaction CVX Common Stock Sale $12,968,285 -72,254 -80% $179.48 17,541 28 Nov 2022 Direct F1, F3
transaction CVX Common Stock Sale $2,950,368 -16,341 -93% $180.55 1,200 28 Nov 2022 Direct F1, F4
transaction CVX Common Stock Sale $217,362 -1,200 -100% $181.14 0 28 Nov 2022 Direct F1, F5
transaction CVX Common Stock Options Exercise $363,515 +2,900 $125.35 2,900 29 Nov 2022 Direct F1
transaction CVX Common Stock Sale $527,146 -2,900 -100% $181.77 0 29 Nov 2022 Direct F1, F6
holding CVX Common Stock 5,777 28 Nov 2022 by 401(k) plan
holding CVX Common Stock 11,552 28 Nov 2022 by JWJ Revocable Trust
holding CVX Common Stock 1,000 28 Nov 2022 by Spouse Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -50,800 -100% $0.000000* 0 28 Nov 2022 Common Stock 50,800 $117.24 Direct F7
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -56,000 -100% $0.000000* 0 28 Nov 2022 Common Stock 56,000 $113.01 Direct F8
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -36,666 -52% $0.000000 33,334 28 Nov 2022 Common Stock 36,666 $110.37 Direct F9
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -2,900 -7.2% $0.000000 37,300 29 Nov 2022 Common Stock 2,900 $125.35 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.
F2 These shares were sold in multiple transactions at prices ranging from $178.05 to $179.04, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
F3 These shares were sold in multiple transactions at prices ranging from $179.05 to $180.04, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F4 These shares were sold in multiple transactions at prices ranging from $180.05 to $181.03, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F5 These shares were sold in multiple transactions at prices ranging from $181.06 to $181.36, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F6 These shares were sold in multiple transactions at prices ranging from $181.73 to $181.85, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F7 Option granted January 25, 2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively.
F8 Option granted January 30, 2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.
F9 Option granted January 29, 2020. One-third of the shares subject to the option vested on January 31, 2021, and one-third of the shares vested on January 31, 2022. The balance of the shares vests on January 31, 2023.
F10 Option granted January 31, 2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.